Tealwood Asset Management Inc Supernus Pharmaceuticals, Inc. Transaction History

Tealwood Asset Management Inc

  • $242 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 16, 2020
SELL
$19.93 - $29.13 $1.5 Million - $2.2 Million
-75,447 Closed
0 $0
Q3 2019

Oct 23, 2019
BUY
$25.47 - $33.37 $47,909 - $62,768
1,881 Added 2.56%
75,447 $2.07 Million
Q2 2019

Aug 06, 2019
BUY
$29.96 - $38.87 $2.2 Million - $2.86 Million
73,566 New
73,566 $2.43 Million

Others Institutions Holding SUPN

# of Institutions
290
Shares Held
60.7M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.05B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Tealwood Asset Management Inc Portfolio

Follow Tealwood Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tealwood Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email